AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT02420587 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: AMG 208
BEHAVIORAL: Questionnaire

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]